Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura

Blood

Volumn 89, Issue 9, 1997, Pages 3097-3103

  Furlan, Miha ^a   Rubles, Rodolfo ^a   Solenthaler, Max ^a   Wassmer, Max ^a   Sandoz, Pierre ^a   Lämmle, Bernhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ARTICLE; CHRONIC DISEASE; DISULFIDE BOND; ELECTROPHORESIS; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IONIC STRENGTH; MEGAKARYOCYTE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0030973267     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3097     Document Type: Article

References (28)

1. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kellon JG, Nair RC, Spasoff RA: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393, 1991
2. Bell WR, Braine HG, Ness PM, Kickler TS: Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325:398, 1991
3. Norkin SA, Freedman HH, Evans GW: Thrombotic thrombocytopenic purpura in siblings. Am J Med 43:294, 1967
4. Wallace DC, Lovric A, Clubb JS, Carseldine DB: Thrombotic thrombocytopenic purpura in four siblings. Am J Med 58:724, 1975
5. Bukowski RM: Thrombotic thrombocytopenic purpura: A review, in Spaet TH (ed): Progress in Hemostasis and Thrombosis. New York, NY, Grune & Stratton, 1982, p 287
6. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D: Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432, 1982
7. Mannucci PM, Lombardi R, Lattuada A, Ruggenenti P, Vigano GL, Barbui T, Remuzzi G: Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Blood 74:978, 1989
8. Sporn LA, Marder VJ, Wagner DD: Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 46:185, 1986
9. Tsai H-M, Nagel RL, Hatcher VB, Sussman II: Multimeric composition of endothelial cell-derived von Willebrand factor. Blood 73:2074, 1989
10. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM:. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand disease. Proc Natl Acad Sei USA 87:6306, 1990
11. Dent JA, Galbusera M, Ruggeri ZM: Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 88:774, 1991
12. Furlan M, Robles R, Affolter D, Meyer D, Baillod P, Lämmle B: Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc Natl Acad Sei USA 90:7503, 1993
13. Kalafatis M, Takahashi Y, Girma J-P, Meyer D: Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365. Blood 70:1577, 1987
14. Federici AB, Bader R, Pagani S, Colibretti ML, De Marco L, Mannucci PM: Binding of von Willebrand factor to glycoproteins Ib and Ilb/IIIa complex: Affinity is related to multimeric size. Br J Haematol 73:93, 1989
15. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Heliums JD: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78:1456, 1986
16. Frangos JA, Moake JL, Nolasco L, Phillips MD, Mclntire LV: Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells. Am J Physiol 256:H1635, 1989
17. Moake JL: Haemolytic-uraemic syndrome: Basic science. Lancet 343:393, 1994
18. Furlan M, Robles R, Lämmle B: Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87:4223, 1996
19. Tsai H-M: Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87:4235, 1996
20. Ruggeri ZM, Zimmerman TS: The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140, 1981
21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage G4. Nature 227:680, 1970
22. Lian ECY, Harkness DR, Byrnes JJ, Wallach H, Nunez R: Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma. Blood 53:333, 1979
23. Murphy WG, Moore JC, Kelton JG: Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Blood 70:1683, 1987
24. Charba D, Moake JL, Harris MA, Hester JP: Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies. Am J Hematol 42:268, 1993
25. Byrnes JJ, Khurana M: Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 297:1386, 1977
26. Moake JL, Bymes JJ, Troll JH, Rudy CK, Hong SL, Weinstein MJ, Colannino NM: Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura. Blood 65:1232, 1985
27. Byrnes JJ, Moake JL: Thrombotic thrombocytopenic purpura and haemolytic-uraemic syndrome: Evolving concepts of pathogenesis and therapy. Clin Haematol 15:413, 1986
28. Tsai HM, Sussman II, Nagel RL: Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 83:2171, 1994